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ABSTRACT 
Background:  Racial disparity in chronic infection with hepatitis B virus is a major 
public health issue in the United States.  Limited data exist on rates of screening and diagnosis 
collected from providers instead of patient self-reported surveys.   
Methods:  Data were extracted from electronic health records (EHRs) of practices in 
New York City for 2013.  Three measures of hepatitis B (Hep B) screening and diagnosis were 
collected: 1) lab tests for hepatitis B virus surface antigen (HBsAg); 2) diagnosis via 
International Classification of Diseases, 9th edition (ICD-9) codes; and 3) of lab tests ordered, 
positive results.  Generalized estimating equation models were used to analyze predictors of Hep 
B screening and diagnosis across three patient groups: Asians who preferred Chinese, Asians 
who preferred English, and non-Asian patients.   
Results:  The study population consisted of 377 practices, with an average of 20% (SD = 
33%) Asian patients per practice.  On average, 5% (SD = 10%), 0.2% (SD = 0.7%), and 1% (SD 
= 5%) of patients in a practice were screened, diagnosed, and HBsAg positive respectively.  
Chinese-preferred Asians were significantly more likely to undergo screening compared to 
English-preferred Asians (beta=0.97, p-value <.01) or non-Asians (beta = 0.89, p-value <.01).  
They were also more likely to be diagnosed compared to English-preferred Asians (beta = 1.78, 
p-value <.01) or non-Asians (beta = 2.96, p-value <.01).   
Discussion:  Practices were significantly more likely to screen for and make diagnosis of 
Hep B among Asian sub-groups, but rates remain low.  This indicates a need for educational 
interventions targeting providers or by integrating Hep B quality metrics in EHRs.  This analysis 
of 2013 data provided a baseline estimate of health care delivery patterns of Hep B of a hard-to-
reach and high-risk population prior to screening recommendation changes in 2014.    
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BACKGROUND 
Racial disparity in chronic infection with hepatitis B virus (HBV) is a major public health 
issue in the United States.  Although the prevalence is less than 0.5% in the general US 
population, approximately 10% of foreign-born Asian American and Pacific Islanders (AAPIs) 
are chronically infected and as many as 65% of them are unaware of their status.1-2  Without 
appropriate treatment and management, one in four chronically infected individuals will die from 
liver cancer and liver failure.3-4  While cardiovascular disease remains the leading cause of death 
in the general US population, AAPI are the only racial group where cancer eclipses 
cardiovascular disease as the dominant killer, with liver cancer ranked 3rd among all cancers.   
 Hepatitis B (Hep B) is a liver disease caused by chronic infection of the hepatitis B virus 
that can lead to cirrhosis, liver failure, and hepatocellular carcinoma, the main type of liver 
cancer.  Of the five main hepatitis virus strains, infection with types A, B, and C account for the 
vast majority of morbidity and mortality world-wide.5  In the US, liver cancer is three times more 
common in men and over 95% of diagnosed individuals are 45 years of age or older.6  In 2011, 
Asians in the US had a mortality rate of 2.72 per 100 from HBV-related causes, compared to 
0.34 in non-Hispanic Whites, 0.94 in non-Hispanic blacks, and 0.43 in Hispanics.5   
Globally Hep B prevalence is higher in most parts of Asia and Sub-Saharan Africa where 
it is endemic (>8% prevalence).5  While horizontal transmission (via contact with infected serum 
or sexual contact with infected individuals) is the most common route of HBV infection in the 
US, vertical transmission from mother to infant at birth is the main driver of infection abroad; 
between 70-90% of infected children under five years of age will be unable to clear the virus.3, 5 
This combined with horizontal transmission via close contact with infected siblings and low 
vaccination rates makes it difficult to reduce childhood incidence rates in Asian countries.7   
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Introduction of childhood HBV vaccination in 1982 have led to a 78% decrease in 
prevalence in the general US population between 1991 and 2005.3  However this strategy will 
have little impact on reducing rates in foreign-born AAPIs as these same programs have had less 
success abroad.  China introduced the vaccine in 1985, but it did not reach Vietnam until 1997.8  
The varying availability of vaccines could explain why coverage varies among immigrants from 
different countries.9  AAPIs are the fastest growing minority group in the US due to the influx of 
immigrants each year; thus, foreign-born individuals from Asia bear a disproportionate burden of 
the disease.   
A study examining racial and ethnic disparities in cancer screening found that birthplace 
was a significant barrier to seeking and receiving care; foreign-born AAPIs were significantly 
less likely to report cancer screening compared to native-born AAPIs and native-born Whites.10  
Previous research has attributed these racial differences to income, education, lack of insurance, 
and geographic residence; after controlling for birthplace, most socioeconomic factors were no 
longer significant predictors.10  Health care providers themselves lack awareness and knowledge 
about what populations constitute high risk groups for chronic HBV infection.11  Inadequate 
screening has resulted in underreporting, and at-risk individuals may not have access to 
preventive services such as screening and vaccination, particularly if physicians don’t initiate 
them.11   
Despite studies documenting the stark disparities in Hep B and liver cancer rates in 
AAPIs compared to the overall US population, little attention has been garnered from both the 
medical sector and the general public toward foreign-born AAPIs as a high-risk group for Hep B 
screening.1  In May 2014, the US Preventive Services Task Force (USPSTF) revised its HBV 
recommendation from a D to a B level, recommending screening and vaccination for high-risk 
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groups, defined as all persons born in areas with high prevalence of HBV infection (≥2%) such 
as Asia.12   
Hep B screening is particularly relevant in a setting like New York City (NYC) which 
has the largest concentration of AAPIs who account for 13% of the entire population.13  
Approximately 37% of the city’s total population are foreign-born compared to 12% nationwide 
and 65-75% of the city’s AAPIs are first generation immigrants.13, 14  Given the diverse and 
growing population of AAPIs, it is important to examine the quality of care they receive in urban 
environments such as NYC, and how quality of care may vary across ethnic sub-groups.   
In this current study, we had a unique opportunity to assess differences in Hep B 
screening and diagnosis among practices serving Asian and Non-Asian patients, using a rich set 
of electronic health record (EHR) data.  In 2008, researchers in NYC attempted to address this 
gap and estimated overall NYC prevalence of 1.2% - two to four times the estimated prevalence 
in the general US population.15  Over 93% of all cases in NYC were among foreign-born 
individuals, and approximately half of those were from China.15  Based on these findings and 
that Chinese-Americans make up 50% of the AAPI community in NYC, this analysis focused on 
Chinese-Americans.   
 
Summary of Current Literature  
 In-depth focus groups among three Asian sub-populations (Korean-, Vietnamese-, and 
Chinese-Americans) revealed limited knowledge about the significance of liver cancer and a 
perceived lack of susceptibility to it.16  Although barriers to screening and vaccination were 
culturally rooted (e.g. stigma and uncleanliness) and systemic to the medical establishment (e.g. 
lack of insurance and language proficiency), religious groups and community members 
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functioned as facilitators for promoting screening and disseminating medical information.16  
Additional barriers included education, years in the US, and provider’s cultural background.9, 17   
A community-based intervention in San Francisco, California sought to dispel the stigma 
surrounding chronic HBV infection by building a city-wide coalition using mass-media 
campaigns and grass-roots messaging to increase awareness, testing, vaccination, and treatment 
among the city’s AAPI population.4  Of the 3,315 AAPIs serologically tested, 6.5% were 
chronically infected; of the 2,639 foreign-born AAPIs, 7.9% were chronically infected.  They 
found that being 41-60 years old, male, of AAPI descent, foreign-born, and lacking a primary 
care provider conferred a significantly higher risk of chronic HBV infection.4   Another outreach 
program in Texas provided culturally appropriate information, testing, vaccination, and linkage 
to medical care.18  They examined HBV-related knowledge, attitudes, and barriers in foreign-
born Vietnamese-Americans and found that a simple education campaign significantly increased 
knowledge related to risk factors, potential consequences and treatment options.   
 In New York City, a community-based program that provided screening and treatment 
was implemented during 2004-2008.19  Approximately 49% of their AAPI population were born 
in China with 36% born in Korea; of 4,301 screened AAPI, 13.3% tested positive, with infection 
rates highest among Chinese (23.2%) and Taiwanese (13.3%).  Adjusting for years lived in the 
US, HBV infection was significantly associated with lower education, being male, and family 
history, with the most important factor being country of birth, especially among Chinese-
Americans compared to other Asian sub-groups.  These risk factors were consistent with ones 
found in other studies.4, 20  Among Chinese-Americans, prevalence varied by geographic region, 
with highest rates among immigrants from the Fujian province (33.1%).  This is important, as it 
is estimated that approximately 80% of Fujianese immigrants reside in NYC.19   
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 In 2009 a “Call to Action” was put forth by Chao et al. citing chronic Hep B as a major 
health disparity that had been overlooked by both the medical community and AAPI population.  
One explanation was the inextricable image of AAPI as a model minority, which has deflected 
attention away from AAPI health problems.1  They identified several systemic gaps contributing 
to the high prevalence and continued disparity, such as the failure to recognize that perinatal 
transmission was the primary mode of infection in AAPIs and physicians’ lack of knowledge on 
how to screen for liver cancer.1  Persons of AAPI descent come from over 50 Asian countries 
and Pacific Islander cultures who speak over 100 languages and dialects.  The classification of 
AAPIs into an aggregated racial group ignores the substantial heterogeneity among the 
subgroups, further masking what little is known about the pattern of disease occurrence and 
changes in incidence over time.21-23    
Primary care providers (PCPs) often act as the point of entry into the US health care 
system and are important in this analysis, as AAPIs often do not feel understood by their doctors, 
participate in decision-making, or seek preventive health services.19  Despite a less than ideal 
patient-provider relationship, physicians are cited as the second biggest source of information, 
and who have the strongest direct effect on screening behavior in their patients.24  It has been 
observed that AAPIs who seek care from providers who speak their language receive more 
health education25; this highlights the importance of language as a barrier for conveying 
information on why patients should be screened.   
 To date, almost all estimates of Hep B prevalence and incidence have come from patient 
questionnaires,14 surveillance-based registries,3 or census-based surveys15; all sources agree that 
these numbers are an underestimate as the majority of patients with advanced liver cirrhosis or 
cancer.  Despite this, screening rates are insufficient as over 50% of AAPIs have not been 
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screened.2, 17  Given the ingrained stigma and lack of insurance in this population, most programs 
have targeted patient-related barriers by mobilizing community support or providing free 
screening.20  As a result, education to increase awareness and funding to provide vaccination and 
treatment have focused primarily on the patient-end of the health care delivery system, 
neglecting to involve providers or address systemic barriers.  Therefore, estimates of screening 
rates and HBV prevalence have mostly been limited to patient self-reports or to intervention 
efforts.20   
EHRs have the potential to be a rich data source for public health research.  Despite 
heavy federal investment, early adoption and advancements in health information technology 
(Health IT) have been framed as a cost-effective tool to integrate and coordinate care between 
physicians, or limited to surveillance, laboratory reporting, and registries.26, 27  Clinically-based 
measurements of the levels and distributions of diseases and functional statuses of the population 
can be expanded to include social and behavioral risk factors such as patient diet, drug use, 
occupational history, and exposure to domestic violence.27  EHRs can also contribute to 
community programs by improving the reporting and investigation of diseases and injuries, as 
well as access to specific EHR information to evaluate time-sensitive public health actions.27  
This analysis aims to estimate Hep B screening rates from the provider-end of the health care 
spectrum, filling in an important knowledge gap.   
 
Study Objectives 
The Primary Care Information Project (PCIP) is a bureau of the New York City 
Department of Health that partners with practices in underserved areas of the city.  PCIP’s 
mission is to improve the quality of preventive services and reduce disparities in healthcare 
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delivery, by utilizing Health IT.  As of 2013, PCIP has partnerships with over 700 practices and 
15,000 providers; a subset of these practices exchange de-identified data with PCIP via an 
electronic querying system called the Hub.  Through the Hub, we are able to ask tailored public 
health questions in the form of structured data queries and to receive electronic data from EHRs 
of the practices in near real time, which can inform interventions aimed at improving health and 
reducing disparities.28  For this analysis, we extracted from the Hub data for the year of 2013 to 
assess rates of Hep B screening and two measures of Hep B diagnosis among Asian patients 
compared to others. The primary objectives are: 
 
1. To examine if there are differential rates of Hepatitis B screening and diagnosis across 3 
groups of patients: Chinese-Preferred Asians, English-Preferred Asians, and non-Asian 
patients.  
 
2. To evaluate if commensurate Hep B screening is being conducted, especially among 
practices serving high proportions of Asian patients.    
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METHODS   
Practice Selection  
All practices included in this study adopted EHR software supplied by a common vendor, 
eClinicalWorks.  Data were extracted remotely from provider EHR systems via structured SQL 
queries; a total of 622 practices returned a full set of queries.  We further restricted to small 
practices (≤25 providers) within NYC zip codes.  All practices needed to have seen at least 50 
adult patients and to have at least one Asian patient in their patient population.  Since lab data 
were relevant to the analysis, we further restricted to practices with an electronic lab interface in 
place.  The final study sample consisted of 377 small practices that met the inclusion criteria 
(Figure 1).  Data related to practice demographics such as location by borough or provider 
specialty were obtained from PCIP’s customer relationship management database, SalesForce.    
 
Hep B Measures and Demographic Variables 
The patient population consists of adults, 20+ years of age with no International 
Classification of Diseases, 9th edition (ICD-9) code of Hep B in their medical records prior to the 
2013 reporting year.  We queried practices on three measures of Hep B screening and diagnosis 
among this population: 1) Those with a lab test ordered for HBV surface antigen (HBsAg); 2) 
Hep B diagnosis via ICD-9 codes; and 3) Among those with a HBsAg lab ordered, those who 
had a positive lab result [Appendix].     
Data were also collected on patient’s self-reported race and ethnicity in their EHR; race 
was categorized into 2 groups – Asian and non-Asian (e.g. White, Hispanic, etc.).   For a patient 
who identified as Asian, we also collected data on their preferred language.  Patients who 
indicated they preferred speaking Mandarin, Cantonese, or “Chinese” were grouped together 
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under Chinese; patients who indicated “English” was placed in its own category and patients 
who preferred other Asian languages (e.g., Tagalog, Punjabi, etc.) were put in the “Other Asian” 
group.  The EHR software has a drop-down menu and free-text box in which race and language 
information are populated; to account for this, queries were coded to include the most common 
spelling permutations for race and ethnicity as well as different preferred Asian languages.   
Counts of patients who met the definition for the three Hep B measures were aggregated 
to the practice center and by race group – Chinese-preferred Asians, English-preferred Asians, 
and non-Asians.  Thus, for each practice, there were three observations per Hep B measure of 
interest for a total of nine observations per practice.  
Access to a primary care provider was a secondary exposure of interest.  A practice was 
defined as “PCP” if it had at least one physician identified as a “primary care provider”.  A 
practice was also defined as serving a “High Asian” population if 25% or more of its patient 
population identified as Asian; this is almost twice the estimated proportion of Asians in NYC.13     
 
Data Analysis  
All statistical analyses were conducted using SAS version 9.3 (SAS Institute Inc., Cary, 
NC, USA).  We used t-tests to assess if there were differences in Hep B screening, diagnosis, and 
HBsAg positive proportions between Asian and non-Asian patients (Table 2).  Within Asians, t-
tests for differences in Hep B measures were also conducted between Chinese-preferred and 
English-preferred patients.  We also conducted bivariate analysis of the secondary exposure to 
interest – presence of PCPs – and gender using logistic regression (table not shown).   
 To assess practice behavior, we used Generalized Estimating Equations (GEE) models to 
estimate the proportion of Hep B screening and diagnosis, adjusting for practice cluster effects 
 14 
and patient volume at each practice.  We did not formally model HBsAg positive proportions due 
to small sample size.  Four models were generated: 1) Hep B screening by 3 race groups (Table 
5), 2) Hep B diagnosis by 3 race groups (Table 6), 3) screening within Asians only (Table 7), 
and 4) diagnosis within Asians only (Table 8).  Practice-level demographics such as patient age 
were practice proportions by age group.  Thus, they were treated as independent variables as 
there was potential for multicollinearity between the three age groups, two gender groups, and 
four poverty groups.  To address this, unadjusted GEE model was conducted using each level 
within the covariate as a single variable regressed against the outcome of interest across all three 
race groups (Table 3) or only within Asians (Table 4).   
Based on the literature, being male, elderly, and having higher poverty are significantly 
associated with Hep B screening and diagnosis.  Significant variables from bivariate analysis 
(Table 3 and Table 4) or known risk factors identified in the literature were entered into the 
multivariate model along with the main effects:  Age groups 40-59 and 60+; poverty group 1 and 
2, and proportions of males were chosen.  Correlation between the two selected age groups was 
5% and between low poverty group and very high poverty group was 43%.  The final model was 
obtained by manual elimination of non-significant variables in an iterative process.  The 
Quasilikelihood under the Independence model Criterion (i.e. QIC) statistic was used to test a 
model’s goodness of fit as variables were removed.   
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RESULTS 
Study Population and Hep B Measures 
The study population consisted of 377 practices and 614,415 patients in 2013.  
Approximately 34% of the practices were located in Queens, 30% in Brooklyn, 24% in 
Manhattan, 10% in the Bronx, and 2% on Staten Island (Table 1).  On average, a practice had 
20% (SD = 33%) of their patients identified as Asian while 71% (SD = 34%) were categorized as 
non-Asian (e.g. White, Black, etc.), and only 9% (SD = 16%) had missing data.  Within Asian 
patients, 64% (SD = 37%) preferred English, 12% (SD = 29%) preferred Chinese, and 8% (SD = 
21%) preferred another Asian language (e.g. Punjabi, Tagalog, etc.) who we classified as “Other 
Asian”; 15% (SD = 26%) preferred languages we did not specify, while only 1% (SD = 5%) had 
missing data.   
The distribution of the proportion of Asian patients in each practice was bimodal, with 
37% (n = 139) of practices having less than 1% of Asian patients, and only 25% of practices (n = 
94) having more than 18% Asians in their total patient population (Figure 2).  Bivariate analysis 
of our secondary exposure showed that women were significantly more likely to present 
themselves at primary care practices compared to men (table not shown).    
Table 2 shows practice averages of Hep B diagnosis, screening, and HBsAg positive 
rates by race and preferred-language within Asian patients.  Within Asians, Chinese-preferred 
patients had more screening (mean = 8.2%, SD = 16.7%) compared to English-preferred (mean = 
4.2%, SD = 9.1%), and this difference was statistically significant (p-value = 0.02); rates of 
diagnosis among Chinese-preferred was three times (mean = 0.6%, SD = 1.2%) that of English-
preferred (mean = 0.2%, SD = 1.5%), and this difference was also significant (p-value = 0.03).    
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Predicting Practice-Level Hep B Screening 
Comparing all three race groups, unadjusted models (Table 3) showed that Asians who 
preferred Chinese (beta = 1.68, SE = 0.27) or English (beta = 0.65, SE = 0.16) were significantly 
more likely to be screened for Hep B compared to non-Asian patients.  PCP practices were 
significantly more likely screen (beta = 0.53, SE = 0.27), as were practices serving a High Asian 
population (beta = 1.56, SE = 0.26).  After controlling for all other covariates, race and a High 
Asian population remained significant predictors of screening in a practice (Table 5).  The final 
model showed that compared to non-Asians, Chinese-preferred Asians (beta = 0.89, SE = 0.24) 
were significantly more likely to be screened, but there was no difference for English-preferred 
Asians (beta = -0.03, SE = 0.16).  Controlling for the effect of race, practices that had more 
elderly patients (60+ years) were less likely to screen them (p-value <.01).     
Table 6 model comparing within Asians showed that Chinese-preferred patients (beta = 
0.97, SE = 0.23) were more likely to be screened than their English-preferred counterparts.  PCP 
practices (beta = 1.66, SE = 0.46) and having a High Asian population (beta = 1.11, SE = 0.28) 
remained significant predictors.  Even within just Asians, practices that served more elderly 
patients were significantly less likely to screen (beta = -0.03, SE = 0.01).    
 
Predicting Practice-Level Hep B Diagnosis 
Unadjusted GEE models revealed Asian race, being a PCP practice and being a High 
Asian serving practice were all significantly associated with more diagnosis (p-value <.01); in 
addition, practices that serve more males had more diagnosis of Hep B (p-value <.01) (Table 3).  
Table 7 shows the adjusted model predicting Hep B diagnosis across the 3 race groups.  After 
adjusting for access to a PCP and High Asian patient volume, Chinese-preferred Asians (beta = 
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2.96, SE = 0.30) and English-preferred Asians (beta = 1.18, SE = 0.23) were significantly more 
likely to have a diagnosis of Hep B compared to non-Asians.  Practices that saw more male 
patients were also significantly more likely to diagnose for Hep B (beta = 0.03, SE = 0.01).   
 Comparing within Asians, Chinese-preferred patients were more likely to have a 
diagnosis (beta = 1.78, SE = 0.29) compared to English-preferred patients even after adjusting 
for PCP practice and a High Asian patient volume in a practice (Table 8).  Again, we see that 
practices serving more male patients were more likely to have Hep B diagnoses (beta = 0.03, SE 
= 0.20), although this relationship was borderline significant (p-value = 0.06). 
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DISCUSSION 
This study showed that there were racial differences in Hep B screening and diagnosis.  
Although screening was higher in Chinese-preferred Asians (8%) compared to English-preferred 
Asians (4%) and non-Asians (4%), these rates were low and cannot account for the 65% of 
undiagnosed Hep B cases in this population.2  Practices that had at least one primary care 
provider or served a high proportion of Asian patients were significantly more likely to screen 
for and make diagnosis of Hep B.  Controlling for age and primary care, Chinese-preferred 
Asians were significantly more likely to be screened and diagnosed compared to English-
preferred Asians and non-Asian patients.  Adjusting for race, practices that saw more males were 
more likely to diagnose Hep B (p-value <.01); this association was marginally significant when 
comparing just among Asians (p-value = 0.06).  Although much lower than expected, the 
numbers are consistent with the literature in that Chinese-Americans (i.e. Chinese-preferred 
Asians) had substantially higher rates of Hep B diagnosis compared to non-Asians – 0.6% vs. 
0.06% respectively (Table 2).   
 With respect to diagnosis, practices with higher ratio of males were significantly more 
likely to have diagnoses of Hep B across all race groups and within Asians, which was consistent 
with the literature.29, 30  Interestingly, although bivariate analysis showed that women were more 
likely to present themselves in practices with primary care providers (OR = 3.05, 95%CI: 2.41, 
3.86), men were more likely to be screened instead.  Pregnant women have been targeted for 
HBV screening as part of routine prenatal care and although pregnancy status was not collected, 
on average a practice had 36% of its patients between the ages of 20 and 39 (Table 1).  This 
combined with a practice average of 62% females suggests that young women of child-bearing 
 19 
age were not receiving screening comparable to men in this population in the year of 2013, 
although it is possible that they might have undergone screening before 2013.   
 Our second objective was to assess if there was commensurate screening for Hep B in 
Asian Americans.  We expected to see that a practice with a high proportion of Asian patients or 
had primary care providers would conduct more screening and diagnosis; our data support this 
hypothesis and suggest that not only are providers acting in their capacity as a gatekeeper by 
providing preventive services, they are also cognizant about HBV-related diseases among their 
Asian patients.  However there are no nationally representative estimates of current screening 
rates among providers, particularly ones serving the AAPI community.  A lack of a benchmark 
rate makes it difficult to assess if a provider conducted “adequate” screening, as adequate 
remains undefined.  Little information has been provided about the frequency and timing of 
screening in this high risk group, unlike the recent change for screening of the hepatitis C virus 
where the USPSTF recommended a one-time life-time screening for HCV in adults born 
between 1945 and 1965.31   
 Despite Asians having significantly more screening, our data suggest that current 
screening behavior can be improved substantially as all proportions were below 10% (Table 2).  
Culturally-tailored programs would be necessary, as there are ethnic-specific differences in 
barriers for HBV screening behaviors and this analysis focused only on Chinese-preferred 
Asians.9, 32  Given the burden of disease in foreign-born AAPIs compared to their native-born 
counterparts, we explored the possibility of using “preferred language” in EHRs as a proxy for 
foreign-born status.  This method does have limitations due to differences in self-identification 
with ethnicity vs. nationality in the AAPI community.   
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Although EHR extracted quality measures and demographic variables (e.g. HA1c level, 
race, etc.) have been shown to be robust and reliable,33 another study found discrepancies in race 
and language derived from EHRs vs. direct self-report by patients.34  Although we can say with 
some confidence that a self-identified Asian patient whose preferred language was Chinese 
would probably be classified as “Chinese-American”, it may not be appropriate to suggest that 
they are foreign-born because they are more comfortable speaking in Chinese compared to 
English.  However, this does highlight the need for better processes to document race and 
language in EHRs – and potentially even integrate foreign-born status into EHR software.   
This analysis is unique with respect to its data source (EHRs) and its perspective, 
providing a snapshot of health care being delivered at the system level.  As EHRs are more 
widely adopted, we have the ability to provide tailored feedback to physicians in near real time.  
Interventions can be targeted not just at clusters of practices, but also at specific patient 
populations within each practice.  Healthcare quality metrics can be integrated into the EHR 
software as electronic prompts for providers.35  It can also be promoted on the provider-end as a 
cost-effective preventive measure that is reimbursable as an important quality measure for 
practices serving a high risk population.  A recent report by the Urban Institute assessed the 
feasibility of using EHR data for research in the AAPI population, citing language barriers, small 
numbers, and differences from study to study in how racial groups are defined and combined; 
these barriers can be circumvented to an extent by utilizing EHRs.36   
However, in order to realize the full potential of Health IT, certain conditions need to be 
met.  First is a specially designated state or federal pool of funds to implement and maintain 
EHRs.  Second, universal coverage of systems and assignment of unique health care identifiers 
are necessary for data collection.  Third, EHR data and transmission processes need to be 
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standardized, which are necessary in order to compare and generalize across different 
populations.  Last, patient privacy and confidentiality must be safeguarded, even if data are 
examined at an aggregate level or in situations where de-identified data are extracted.27    
One of the major strengths of this analysis is that data were extracted directly from EHRs 
in order to evaluate practice behaviors of Hep B screening from the health system end, whereas 
previous estimates have relied on patient self-reports or local community interventions; thus it is 
less susceptible to bias.  The second strength is our large sample size of 377 practices and over 
600,000 patients, whereas previous estimates have suffered from under-reporting and small 
sample size due to a small Asian population.  The relative speed and magnitude of information 
that can be harnessed from pulling epidemiologic variables from EHRs have powerful 
implications for improving population health in NYC and beyond.  Third, the data were gathered 
retrospectively from EHRs for reporting year 2013 and as such, they provide a baseline estimate 
of screening behavior before the 2014 USPSTF recommendation change for Hep B screening.12  
Further analysis of data from 2014 and 2015 reporting year will provide a good “before” and 
“after” snapshot of whether or not provider and public awareness of the risk factors for Hep B 
have increased.   
There are a few inherent limitations in the collection and utilization of EHR data.  In 
order to protect human subjects, data have to be de-identified.  The extremely low prevalence of 
Hep B in the general public, combined with language-stratification within Asians, resulted in 
small patient counts; this made it easier to identify patients in a practice.  Thus, our data were 
aggregated and analyzed at the practice level.  Second, there is a lack of standardization in EHR 
platforms; only practices that had adopted the eClinicalWorks software were included in the 
study.  Results and observations may not be generalizable to practices using different systems 
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and may not be generalizable outside of NYC.  Data related to provider-language capability and 
translator services offered at a practice were not available, potentially confounding the 
relationship between patient’s race and provider screening and diagnosis patterns.   
Under the Patient Protection and Affordable Care Act, most health plans are required to 
financially cover levels A & B screening recommendations by the USPSTF.  This will mitigate 
cost as one of the major patient and provider barriers to screening; more attention and resources 
can be diverted to providing anti-viral medications and chronic disease management.17  Although 
this cannot address barriers on the patient-end such as social stigma and language proficiency, 
educational interventions aimed at raising physician awareness and electronic prompts at the 
provider-end of the health delivery spectrum will have a positive impact.26  This change has 
several repercussions for the primary stakeholders, from the patient seeking care to the provider 
offering services and the payer footing the bill.   
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CONCLUSION 
Chronic infection with HBV is the most preventable cause of liver failure, cirrhosis, and 
liver cancer among AAPIs.  Our findings reveal that controlling for a high Asian patient 
population, practices were more likely to screen Chinese-preferred Asians or all Asian patients 
compared to patients of other races.  This demonstrates a need for culturally tailored 
interventions targeted at providers specifically, as education and outreach campaigns have 
already been shown to be effective in increasing Hep B awareness and screening at the patient-
end.4, 18, 19  This analysis provides a “before” snapshot of Hep B screening and diagnosis 
behavior from the provider-end before recommendations were updated in 2014.  This 
exploratory analysis provides an important opportunity to evaluate how and to what extent 
epidemiologic variables could be extracted for public health research and inform preventative 
care interventions.  Electronic health records represent a potentially rich, untapped data source 
for conducting population health based research in hard-to-reach and high-risk populations.   
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Table 1.  Study Practice Characteristics for Reporting Year 2013 (N=377)a 
Patient Characteristics Meanb SDc 
Average Patient Volume 1,843 ± 1,642 
Average Number of Providers 3 ± 5 
Average % of Race    
     Asian 20% ± 33% 
     Non-Asian 71% ± 34% 
     Missing 9% ± 16% 
Average % of Preferred Language 
Among Asians    
     Chinese 12% ± 29% 
     English 64% ± 37% 
     Other Asian 8% ± 21% 
     None of the Above 15% ± 26% 
     Missing 1% ± 8% 
Hepatitis B Measure   
     Screening 5% ± 10% 
     Diagnosis 0.2% ± 0.7% 
     HBsAg Positive 1% ± 5% 
   
Practice Demographics Meanb SDc 
Average % Patient Age    
     20 – 39  36% ± 20% 
     40 – 59  36% ± 10% 
     60 – 100+ 28% ± 17% 
Average % Patient Gender   
     Female 62% ± 15% 
     Male 38% ± 15% 
Average % Patient Poverty Groupd   
     Low (wealthiest) 16% ± 18% 
     Medium  39% ± 24% 
     High 27% ± 21% 
     Very High 17% ± 23% 
   
Borough nb (%)c 
Brooklyn 113 30% 
Bronx 38 10% 
Manhattan 89 24% 
Staten Island 9 2% 
Queens 128 34% 
   
a Numbers may not sum to total due to missing data, and percentages may not sum to 100% due to rounding. 
b Table values are mean for proportions and n for categorical variables. 
c Table values are ± SD for proportions and column % for categorical variables. 
d Poverty groups defined as percent of residents in NYC zip code with incomes below 100% of the federal poverty 
line (ACS 2007-2011) separated into 4 groups: low (<10%), medium (10%-<20%), high (20-<30%), and very high 
(≥30%).   
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Table 2:   Practice Averages of Hep B Measures by Race and Preferred Language (N=377) 
  Patient Racea   
Hep B Measure 
Asian  
(mean % ± SD) 
Non-Asian  
(mean % ± SD) 
t-test p-value 
Screening   4.5% ± 11.6% 4.3% ± 9.2% 0.26 0.80 
Diagnosis 0.3% ± 1.5% 0.06% ± 0.3% 2.80 <.01 
HBsAg Positive  2.7% ± 8.3% 0.8% ± 6.4% 2.27 0.02 
  Within Asians, Preferred Languagea   
Hep B Measure 
Chinese 
(mean % ± SD) 
English 
(mean % ± SD) 
t-test p-value 
Screening  8.2% ± 16.7% 4.2% ± 9.1% 2.41 0.02 
Diagnosis  0.6% ± 1.2% 0.2% ± 1.5% 2.20 0.03 
HBsAg Positive  3.6% ± 7.5% 3.8% ± 13.3% -0.13 0.90 
a Table values are mean ± SD for proportions 
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Table 3.  Unadjusted GEE Model Predicting Hep B Screening and Diagnosis by Race  
Practice Characteristics 
Screening Association (N=377) Diagnosis Association (N=377) 
Beta (SE) p-value Beta (SE) p-value 
Patient Race     
     Non-Asian Reference --- Reference --- 
     English-Preferred Asian 0.65 (0.16) <.01 1.63 (0.28) <.01 
     Chinese-Preferred Asian 1.68 (0.27) <.01 3.38 (0.33) <.01 
PCP Practicea     
     No Reference --- Reference --- 
     Yes 0.53 (0.27) 0.05 1.04 (0.49) 0.03 
High Asian Practiceb     
     No Reference --- Reference --- 
     Yes 1.56 (0.26) <.01 3.01 (0.34) <.001 
     
Practice % Patient Age      
     20 – 39  0.02 (0.005) <.01 -0.002 (0.01) 0.86 
     40 – 59  0.01 (0.02) 0.65 0.04 (0.02) 0.14 
     60 – 100+ -0.03 (0.01) <.01 -0.005 (0.01) 0.61 
Practice % Patient Gender     
     Female -0.004 (0.005) 0.47 -0.03 (0.01) <.01 
     Male 0.004 (0.005) 0.47 0.03 (0.01) <.01 
Practice % Patient Poverty Groupc     
     Low (wealthiest) -0.02 (0.01) 0.02 -0.02 (0.01) 0.08 
     Medium  0.001 (0.01) 0.90 0.004 (0.01) 0.74 
     High 0.01 (0.01) 0.12 0.02 (0.01) 0.04 
     Very High -0.004 (0.01) 0.54 -0.03 (0.01) <.01 
Practice Location by Borough     
     Bronx Reference --- Reference --- 
     Brooklyn 0.58 (0.47) 0.22 1.80 (0.53) <.01 
     Manhattan -0.06 (0.43) 0.88 0.85 (0.44) 0.05 
     Staten Island -1.05 (0.43) 0.02 -1.13 (1.01) 0.26 
     Queens 0.38 (0.45) 0.39 1.67 (0.49) <.01 
     
a Practice defined as having ≥1 primary care providers working at that practice   
b Practice defined as having ≥25% of Asian patients at that practice 
c Poverty groups defined as percent of residents in NYC zip code with incomes below 100% of the federal poverty 
line (ACS 2007-2011) separated into 4 groups: low (<10%), medium (10%-<20%), high (20-<30%), and very high 
(≥30%).   
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Table 4.  Unadjusted GEE Model Predicting Hep B Screening and Diagnosis within Asians  
Practice Characteristics 
Screening Association (N=377) Diagnosis Association (N=377) 
Beta (SE) p-value Beta (SE) p-value 
Patient Race     
     English-Preferred Asian Reference --- Reference --- 
     Chinese-Preferred Asian 1.03 (0.23) <.01 1.75 (0.27) <.01 
PCP Practicea     
     No Reference --- Reference --- 
     Yes 1.36 (0.41) <.01 1.83 (0.61) <.01 
High Asian Practiceb     
     No Reference --- Reference --- 
     Yes 1.46 (0.35) <.01 1.89 (0.36) <.01 
     
Practice % Patient Age     
     20 – 39  0.01 (0.01) 0.15 -0.01 (0.01) 0.30 
     40 – 59  0.03 (0.03) 0.33 0.005 (0.02) 0.83 
     60 – 100+ -0.02 (0.01) 0.04 0.01 (0.01) 0.30 
Practice % Patient Gender     
     Female 0.03 (0.01) <.01 0.04 (0.01) <.01 
     Male 0.03 (0.01) <.01 0.04 (0.01) <.01 
Practice % Patient Poverty Groupc      
     Low (wealthiest) -0.03 (0.02) 0.21 -0.01 (0.02) 0.40 
     Medium  -0.01 (0.01) 0.41 -0.01 (0.01) 0.34 
     High 0.01 (0.01) 0.25 0.01 (0.01) 0.20 
     Very High 0.01 (0.01) 0.33 -0.003 (0.02) 0.88 
Practice Location by Borough     
     Bronx Reference --- Reference --- 
     Brooklyn 2.86 (0.66) <.01 2.86 (1.07) <.01 
     Manhattan 1.27 (0.71) 0.08 1.68 (1.09) 0.12 
     Staten Island 0.96 (0.64) 0.13 1.19 (1.08) 0.27 
     Queens 2.18 (0.68) <.01 2.28 (1.03) 0.04 
     
a Practice defined as having ≥1 primary care providers working at that practice   
b Practice defined as having ≥25% of Asian patients at that practice 
c Poverty groups defined as percent of residents in NYC zip code with incomes below 100% of the federal poverty 
line (ACS 2007-2011) separated into 4 groups: low (<10%) and very high (≥30%).   
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Table 5.  Adjusted and Final GEE Models Predicting Hep B Screening by Race  
Practice Characteristics 
Multivariate Model (N=377) Final Model (N=377) 
Beta (SE) p-value Beta (SE) p-value 
Patient Race     
     Non-Asian Reference --- Reference --- 
     English-Preferred Asian 0.03 (0.15) 0.82 -0.03 (0.16) 0.86 
     Chinese-Preferred Asian 0.91 (0.26) <.01 0.89 (0.24) <.01 
PCP Practicea     
     No Reference --- Reference --- 
     Yes 0.68 (0.40) 0.09 0.97 (0.35) <.01 
High Asian Practiceb     
     No Reference --- Reference --- 
     Yes 0.94 (0.27) <.01 0.97 (0.22) <.01 
     
Practice % Patient Age     
     40 – 59 -0.01 (0.01) 0.37   
     60 – 100+ -0.03 (0.01) <.01 -0.03 (0.01) <.01 
Practice % Patient Gender  0.77 (0.80) 0.33   
     Male     
Practice % Patient Poverty Groupc     
     Low (wealthiest) -0.003 (0.01) 0.74   
     Very High (poorest) 0.003 (0.01) 0.70   
Practice Location by Borough     
     Bronx Reference ---   
     Brooklyn -0.07 (0.39) 0.85   
     Manhattan -0.45 (0.44) 0.30   
     Staten Island -0.47 (0.68) 0.49   
     Queens -0.11 (0.46) 0.81   
     
a Practice defined as having ≥1 primary care providers working at that practice   
b Practice defined as having ≥25% of Asian patients at that practice 
c Poverty Groups defined as percent of residents in NYC zip code with incomes below 100% of the federal poverty 
line (ACS 2007-2011): low (<10%) and very high (≥30%).   
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Table 6.  Adjusted and Final GEE Models Predicting Hep B Screening within Asians  
Practice Characteristics 
Multivariate Model (N=377) Final Model (N=377) 
Beta (SE) p-value Beta (SE) p-value 
Race     
     English-Preferred Asian Reference --- Reference --- 
     Chinese-Preferred Asian 0.88 (0.27) <.01 0.97 (0.23) <.01 
PCP Practicea     
     No Reference --- Reference --- 
     Yes 0.76 (0.62) 0.23 1.66 (0.46) <.01 
High Asian Practiceb     
     No Reference --- Reference --- 
     Yes 0.96 (0.39) 0.01 1.11 (0.28) <.01 
     
Practice % Patient Age     
     40 – 59 0.001 (0.02) 0.95   
     60 – 100+ -0.03 (0.01) <.01 -0.03 (0.01) <.01 
Practice % Patient Gender 0.02 (0.01) 0.10   
     Male     
Practice % Patient Poverty Groupc     
     Low (wealthiest) 0.01 (0.01) 0.20   
     Very High (poorest) -0.02 (0.02) 0.32   
Practice Location by Borough     
     Bronx Reference ---   
     Brooklyn 0.56 (0.86)  0.51    
     Manhattan -0.47 (0.93) 0.61   
     Staten Island -1.12 (1.06) 0.29   
     Queens -0.06 (0.96) 0.95   
     
a Practice defined as having ≥1 primary care providers working at that practice   
b Practice defined as having ≥25% of Asian patients at that practice 
c Poverty Groups defined as percent of residents in NYC zip code with incomes below 100% of the federal poverty 
line (ACS 2007-2011): low (<10%) and very high (≥30%).   
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Table 7.  Adjusted and Final GEE Models Predicting Hep B Diagnosis by Race 
Practice Characteristics 
Multivariate Model (N=377) Final Model (N=377) 
Beta (SE) p-value Beta (SE) p-value 
Patient Race     
     Non-Asian Reference --- Reference --- 
     Chinese-Preferred Asian 3.10 (0.34) <.01 2.96 (0.30) <.01 
     English-Preferred Asian 1.15 (0.29) <.01 1.18 (0.23) <.01 
PCP Practicea     
     No Reference --- Reference --- 
     Yes 1.04 (0.50) 0.04 1.16 (0.54) 0.03 
High Asian Practiceb     
     No Reference --- Reference --- 
     Yes 0.51 (0.30) 0.09 0.76 (0.29) 0.01 
     
Practice % Patient Age     
      40 – 59 0.01 (0.02) 0.73   
      60 – 100+ 0.01 (0.01) 0.50   
Practice % Patient Gender     
     Male 0.04 (0.01) <.01 0.03 (0.01) <.01 
Practice % Patient Poverty Groupc     
     Low (wealthiest) -0.003 (0.01) 0.73   
     Very High (poorest) -0.01 (0.01) 0.33   
Practice Location by Borough     
     Bronx Reference ---   
     Brooklyn -0.50 (0.52) 0.33    
     Manhattan -1.04 (0.59) 0.08   
     Staten Island -1.53 (1.13) 0.18   
     Queens -0.24 (0.63) 0.70   
     
a Practice defined as having ≥1 primary care providers working at that practice   
b Practice defined as having ≥25% of Asian patients at that practice 
c Poverty Groups defined as percent of residents in NYC zip code with incomes below 100% of the federal poverty 
line (ACS 2007-2011): low (<10%) and very high (≥30%).   
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Table 8.  Adjusted and Final GEE Models Predicting Hep B Diagnosis within Asians  
Practice Characteristics 
Multivariate Model (N=377) Final Model (N=377) 
Beta (SE) p-value Beta (SE) p-value 
Patient Race     
     English-Preferred Asian Reference --- Reference --- 
     Chinese-Preferred Asian 1.75 (0.29) <.01 1.78 (0.29) <.01 
PCP Practicea     
     No Reference --- Reference --- 
     Yes 1.18 (0.70) 0.09 1.37 (0.74) 0.06 
High Asian Practiceb     
     No Reference --- Reference --- 
     Yes 0.73 (0.36) 0.04 0.81 (0.31) 0.01 
     
Practice % of Patient Age     
     40 – 59 -0.01 (0.02) 0.62   
     60 – 100+ 0.002 (0.01) 0.80   
Practice % of Patient Gender     
     Male 0.03 (0.02) 0.03 0.03 (0.02) 0.06 
Practice % Patient Poverty Groupc     
     Low (wealthiest) 0.003 (0.01) 0.80   
     Very High (poorest) -0.08 (0.04) 0.07   
Practice Location by Borough     
     Bronx Reference ---   
     Brooklyn -1.10 (1.39)  0.43    
     Manhattan  -1.48 (1.22) 0.22   
     Staten Island  -1.27 (1.58) 0.42   
     Queens  -0.06 (0.96) 0.95   
     
a Practice defined as having ≥1 primary care providers working at that practice   
b Practice defined as having ≥25% of Asian patients at that practice 
c Poverty Groups defined as percent of residents in NYC zip code with incomes below 100% of the federal poverty 
line (ACS 2007-2011): low (<10%) and very high (≥30%).   
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Figure 1:  Flow Chart of Inclusion and Exclusion Criteria 
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Figure 2:  Histogram of Practice Proportions of Asian Patients (N=377) 
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APPENDIX 
 
Definition of Hepatitis B Measures Extracted from provider EHRs:   
 
Patient Sample:  Restricted to adults aged 20 years and older with no diagnosis of Hepatitis B 
prior to 2013 reporting year.   
 
Screening = 
Counts of patients who had a lab test ordered for HBsAg in 2013 
All Unique Patients who had a doctor′s visit in 2013
 
 
Diagnosis = 
Counts of patients who had an ICD−9 code for Hepatitis B in 2013
All Unique Patients who had a doctor′s visit in 2013
 
 
HBsAg Positive = 
Counts of patients who had a positive lab test for HBsAg in 2013
Counts of patients who had a lab test ordered for HBsAg in 2013
 
 
 
NOTE:  The numerator for the “Screening” variable is the denominator for the “Lab Positive” 
variable.   
  
 35 
REFERENCES  
1. Chao, S.D., E.T. Chang, and S.K. So, Eliminating the threat of chronic hepatitis B in the 
Asian and Pacific Islander community: a call to action. Asian Pac J Cancer Prev, 2009. 
10(3): p. 507-12. 
 
2. Lin, S.Y., E.T. Chang, and S.K. So, Why we should routinely screen Asian American 
adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology, 2007. 
46(4): p. 1034-40. 
 
3. Center for Disease Control, Viral Hepatitis Surveillance – United States, 2011. 2011 
August 19, 2013 [cited 2014 June 23, 2014]; Available from: 
http://www.cdc.gov/hepatitis/Statistics/2011Surveillance/. 
 
4. Bailey, M.B., et al., San Francisco hep B free: a grassroots community coalition to 
prevent hepatitis B and liver cancer. J Community Health, 2011. 36(4): p. 538-51. 
 
5. World Health Organization, Hepatitis B. March 2015 [cited 2014 August 15, 2014]; 
Available from: http://www.who.int/mediacentre/factsheets/fs204/en/. 
 
6. American Cancer Society. What are the key statistics about liver cancer? January 13, 
2015 [cited 2015 March 29, 2015]; Available from: 
http://www.cancer.org/cancer/livercancer/detailedguide/liver-cancer-what-is-key-
statistics. 
 
7. Dufour, D.R., Hepatitis B surface antigen (HBsAg) assays--are they good enough for 
their current uses? Clin Chem, 2006. 52(8): p. 1457-9. 
 
8. Lesmana, L.A., et al., Hepatitis B: overview of the burden of disease in the Asia-Pacific 
region. Liver International, 2006. 26(S2): p. 3-10. 
 
9. Strong, C., et al., Ethnic differences in prevalence and barriers of HBV screening and 
vaccination among Asian Americans. J Community Health, 2012. 37(5): p. 1071-80. 
 
10. Goel, M.S., et al., Racial and ethnic disparities in cancer screening: the importance of 
foreign birth as a barrier to care. J Gen Intern Med, 2003. 18(12): p. 1028-35. 
 
11. Institute of Medicine., Hepatitis and Liver Cancer: A National Strategy for Prevention 
and Control of Hepatitis B and C, H.M. Colvin and A.E. Mitchell, Editors. 2010, The 
National Academies Press: Washington, DC. 
 
12. LeFevre, M.L., Screening for hepatitis B virus infection in nonpregnant adolescents and 
adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med, 
2014. 161(1): p. 58-66. 
 
13. US Census Bureau, The Asian Population: 2010. 2012, U.S. Census Bureau. 
 36 
14. Trinh-Shevrin, C., et al., The Asian American hepatitis B program: building a coalition to 
address hepatitis B health disparities. Prog Community Health Partnersh, 2011. 5(3): p. 
261-71. 
 
15. France, A.M., et al., Estimating the prevalence of chronic hepatitis B virus infection--
New York City, 2008. J Urban Health, 2012. 89(2): p. 373-83. 
 
16. Philbin, M.M., et al., Hepatitis B and liver cancer among three Asian American sub-
groups: a focus group inquiry. J Immigr Minor Health, 2012. 14(5): p. 858-68. 
 
17. Hu, K.Q., C.Q. Pan, and D. Goodwin, Barriers to screening for hepatitis B virus infection 
in Asian Americans. Dig Dis Sci, 2011. 56(11): p. 3163-71. 
 
18. Zacharias, T., et al., HBV Outreach Programs Significantly Increase Knowledge and 
Vaccination Rates Among Asian Pacific Islanders. J Community Health, 2014. 
 
19. Pollack, H.J., et al., Chronic hepatitis B and liver cancer risks among Asian immigrants 
in New York City: Results from a large, community-based screening, evaluation, and 
treatment program. Cancer Epidemiol Biomarkers Prev, 2014. 23(11): p. 2229-39. 
 
20. Rein, D.B., et al., Community-based hepatitis B screening programs in the United States 
in 2008. J Viral Hepat, 2010. 17(1): p. 28-33. 
 
21. Chang, E.T., et al., The burden of liver cancer in Asians and Pacific Islanders in the 
Greater San Francisco Bay Area, 1990 through 2004. Cancer, 2007. 109(10): p. 2100-8. 
 
22. Ghosh, C., Healthy People 2010 and Asian Americans/Pacific Islanders: defining a 
baseline of information. Am J Public Health, 2003. 93(12): p. 2093-8. 
 
23. Holland, A.T. and L.P. Palaniappan, Problems with the collection and interpretation of 
Asian-American health data: omission, aggregation, and extrapolation. Ann Epidemiol, 
2012. 22(6): p. 397-405. 
 
24. Tanaka, M., et al., Influence of information sources on hepatitis B screening behavior 
and relevant psychosocial factors among Asian immigrants. J Immigr Minor Health, 
2013. 15(4): p. 779-87. 
 
25. Chu, D., et al., Hepatitis B screening and vaccination practices in asian american 
primary care. Gut Liver, 2013. 7(4): p. 450-7. 
 
26. El-Kareh, R., O. Hasan, and G.D. Schiff, Use of health information technology to reduce 
diagnostic errors. BMJ Qual Saf, 2013. 22 Suppl 2: p. ii40-ii51. 
 
27. Friedman, D.J., R.G. Parrish, and D.A. Ross, Electronic health records and US public 
health: current realities and future promise. Am J Public Health, 2013. 103(9): p. 1560-
7. 
 37 
28. Buck, M.D., et al., The Hub Population Health System: distributed ad hoc queries and 
alerts. J Am Med Inform Assoc, 2012. 19(e1): p. e46-50. 
 
29. Baig, S., Gender disparity in infections of Hepatitis B virus. J Coll Physicians Surg Pak, 
2009. 19(9): p. 598-600. 
 
30. Liu, W.C. and Q.Y. Liu, Molecular mechanisms of gender disparity in hepatitis B virus-
associated hepatocellular carcinoma. World J Gastroenterol, 2014. 20(20): p. 6252-61. 
 
31. Moyer, V.A., Screening for hepatitis C virus infection in adults: U.S. Preventive Services 
Task Force recommendation statement. Ann Intern Med, 2013. 159(5): p. 349-57. 
 
32. Maxwell, A.E., et al., Developing theoretically based and culturally appropriate 
interventions to promote hepatitis B testing in 4 Asian American populations, 2006-2011. 
Prev Chronic Dis, 2014. 11: p. E72. 
 
33. Parsons, A., et al., Validity of electronic health record-derived quality measurement for 
performance monitoring. J Am Med Inform Assoc, 2012. 19(4): p. 604-9. 
 
34. Klinger, E.V., et al., Accuracy of Race, Ethnicity, and Language Preference in an 
Electronic Health Record. J Gen Intern Med, 2014. 
 
35. Hsu, L., et al., Electronic messages increase hepatitis B screening in at-risk Asian 
American patients: a randomized, controlled trial. Dig Dis Sci, 2013. 58(3): p. 807-14. 
 
36. Devers, K., et al., The feasibility of using electronic health records (EHRs) and other 
electronic health data for research on small populations.  . 2013, Urban Institute. 
 
